Pharmaceutical

Cyber Security for Pharmaceutical

As pharmaceutical and biotechnology companies move toward greater digitalization and the sharing and storage of highly valuable data, their digital security practices, including Privileged Access Management to protect against insider threats, are becoming more critical. Many pharma labs and manufacturing facilities, for example, are relying on the Industrial Internet of Things to automate and improve their highly sensitive processes. In addition to securing physical endpoints and entire manufacturing plants, pharma and biotech companies store and share proprietary information associated with drugs, medical devices, and other advances. Given the extremely sensitive nature of data collected and used by pharmaceutical and biotechnology companies in clinical trials and patient management, security measures are particularly important to ensure trust and protect reputations. Traditional cybersecurity solutions are focused on reporting intrusions after they occur, focused on incident response. New solutions are addressing the prevention of attacks, and secure access management technologies, like those Kron Technologies has perfected in our own labs, are becoming a cornerstone of a comprehensive means to reduce the risk of growing insider threats.